In contrast to animal studies, evidence that IFNAR1 signaling contributes to TB disease susceptibility in humans is unclear, although several clinical studies have linked the blood interferon signature to detrimental clinical outcome16–18. This evidence concerns the gene IFNAR1 and tuberculosis.